Featured Research

from universities, journals, and other organizations

CT: The first-line imaging choice of physicians for the diagnosis of pulmonary embolism

Date:
December 22, 2009
Source:
American College of Radiology / American Roentgen Ray Society
Summary:
Computed tomography, a highly accurate, readily available medical imaging technique, is the overwhelmingly preferred technique of emergency physicians and radiologists for the diagnosis of pulmonary embolism.

Computed tomography (CT), a highly accurate, readily available medical imaging technique, is the overwhelmingly preferred technique of emergency physicians and radiologists for the diagnosis of pulmonary embolism (PE), according to a new study.

PE, the formation of a blood clot in the lung, is a life-threatening condition that requires prompt diagnosis and treatment. Medical imaging techniques such as CT, lung scintigraphy, and MRI are currently available to physicians to diagnose PE. "The purpose of our study was to assess the diagnostic approach to PE practiced by emergency physicians and advised by radiologists," said Saurabh Jha, MD, lead author of the study.

Questionnaires were sent to emergency physicians and radiologists in Pennsylvania. The questions covered diagnostic strategies for the detection of PE. "Emergency physicians nearly uniformly (96 percent) chose CT as the preferred first-line investigation. They cited accuracy as one of the major determinants of their choice, followed by overall access to CT, availability of 24-hour interpretation, and capability for alternative diagnosis. Ninety percent of radiologists reported that the first-line medical imaging technique for excluding pulmonary embolism at their hospital was CT," said Jha.

"The results of our study indicate that by a large margin, both emergency physicians and radiologists prefer CT in the diagnosis of PE. In imaging of pregnant patients to whom radiation is of concern, approaches differed," he said.

"CT is the nearly universal first-line imaging choice for the diagnosis of PE. This is not surprising considering its accuracy is well established," said Jha.


Story Source:

The above story is based on materials provided by American College of Radiology / American Roentgen Ray Society. Note: Materials may be edited for content and length.


Cite This Page:

American College of Radiology / American Roentgen Ray Society. "CT: The first-line imaging choice of physicians for the diagnosis of pulmonary embolism." ScienceDaily. ScienceDaily, 22 December 2009. <www.sciencedaily.com/releases/2009/12/091222121805.htm>.
American College of Radiology / American Roentgen Ray Society. (2009, December 22). CT: The first-line imaging choice of physicians for the diagnosis of pulmonary embolism. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/12/091222121805.htm
American College of Radiology / American Roentgen Ray Society. "CT: The first-line imaging choice of physicians for the diagnosis of pulmonary embolism." ScienceDaily. www.sciencedaily.com/releases/2009/12/091222121805.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins